Free Trial

Camtek (CAMT) Competitors

Camtek logo
$75.69 +1.25 (+1.68%)
Closing price 04:00 PM Eastern
Extended Trading
$76.54 +0.85 (+1.12%)
As of 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CAMT vs. RVTY, AVTR, BIO.B, NVMI, VNT, MIR, ST, TXG, TRNS, and ALNT

Should you be buying Camtek stock or one of its competitors? The main competitors of Camtek include Revvity (RVTY), Avantor (AVTR), Bio-Rad Laboratories (BIO.B), Nova (NVMI), Vontier (VNT), Mirion Technologies (MIR), Sensata Technologies (ST), 10x Genomics (TXG), Transcat (TRNS), and Allient (ALNT). These companies are all part of the "measuring and control equipment" industry.

Camtek vs.

Camtek (NASDAQ:CAMT) and Revvity (NYSE:RVTY) are both computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, community ranking, institutional ownership, analyst recommendations, risk, profitability and earnings.

Camtek pays an annual dividend of $1.33 per share and has a dividend yield of 1.8%. Revvity pays an annual dividend of $0.28 per share and has a dividend yield of 0.3%. Camtek pays out 51.0% of its earnings in the form of a dividend. Revvity pays out 11.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

41.9% of Camtek shares are owned by institutional investors. Comparatively, 86.7% of Revvity shares are owned by institutional investors. 79.4% of Camtek shares are owned by company insiders. Comparatively, 0.7% of Revvity shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Camtek has a net margin of 27.61% compared to Revvity's net margin of 9.81%. Camtek's return on equity of 24.99% beat Revvity's return on equity.

Company Net Margins Return on Equity Return on Assets
Camtek27.61% 24.99% 14.81%
Revvity 9.81%7.68%4.62%

Camtek received 528 more outperform votes than Revvity when rated by MarketBeat users. Likewise, 71.09% of users gave Camtek an outperform vote while only 62.50% of users gave Revvity an outperform vote.

CompanyUnderperformOutperform
CamtekOutperform Votes
563
71.09%
Underperform Votes
229
28.91%
RevvityOutperform Votes
35
62.50%
Underperform Votes
21
37.50%

Revvity has higher revenue and earnings than Camtek. Camtek is trading at a lower price-to-earnings ratio than Revvity, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Camtek$450.86M7.65$118.51M$2.6129.00
Revvity$2.77B4.10$270.39M$2.3540.96

In the previous week, Camtek had 1 more articles in the media than Revvity. MarketBeat recorded 6 mentions for Camtek and 5 mentions for Revvity. Camtek's average media sentiment score of 1.47 beat Revvity's score of 0.97 indicating that Camtek is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Camtek
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Revvity
4 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Camtek currently has a consensus price target of $90.78, suggesting a potential upside of 19.93%. Revvity has a consensus price target of $125.64, suggesting a potential upside of 30.53%. Given Revvity's higher possible upside, analysts clearly believe Revvity is more favorable than Camtek.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Camtek
0 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
3.00
Revvity
0 Sell rating(s)
4 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
2.80

Camtek has a beta of 1.29, indicating that its share price is 29% more volatile than the S&P 500. Comparatively, Revvity has a beta of 0.97, indicating that its share price is 3% less volatile than the S&P 500.

Summary

Camtek beats Revvity on 13 of the 20 factors compared between the two stocks.

Get Camtek News Delivered to You Automatically

Sign up to receive the latest news and ratings for CAMT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CAMT vs. The Competition

MetricCamtekOptical instruments & lenses IndustryComputer SectorNASDAQ Exchange
Market Cap$3.45B$15.42B$26.25B$8.66B
Dividend Yield2.25%1.61%2.86%4.19%
P/E Ratio31.2840.8945.1820.17
Price / Sales7.655.882,031.83161.90
Price / Cash39.5320.2234.7434.64
Price / Book6.257.277.084.72
Net Income$118.51M$324.03M$740.66M$247.80M
7 Day Performance11.24%5.13%4.00%3.36%
1 Month Performance13.70%12.47%7.39%9.71%
1 Year Performance-32.15%2.91%52,442.62%14.41%

Camtek Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CAMT
Camtek
4.0562 of 5 stars
$75.69
+1.7%
$90.78
+19.9%
-32.0%$3.45B$450.86M31.28400Positive News
Analyst Revision
RVTY
Revvity
3.8661 of 5 stars
$89.26
-1.3%
$125.64
+40.8%
-16.2%$10.52B$2.77B40.3916,700
AVTR
Avantor
4.969 of 5 stars
$12.96
+0.4%
$18.88
+45.6%
-43.9%$8.83B$6.69B12.4614,500Positive News
BIO.B
Bio-Rad Laboratories
N/A$250.08
flat
N/A-13.3%$7.00B$2.54B-3.858,200
NVMI
Nova
2.8013 of 5 stars
$211.80
-0.9%
$277.00
+30.8%
+0.6%$6.23B$743.95M36.901,180
VNT
Vontier
3.8714 of 5 stars
$35.63
-0.3%
$44.83
+25.8%
-6.4%$5.27B$2.96B12.968,100Positive News
MIR
Mirion Technologies
1.1648 of 5 stars
$19.25
+0.8%
$18.75
-2.6%
+108.0%$4.46B$870.20M-101.292,870
ST
Sensata Technologies
4.8418 of 5 stars
$25.71
-1.3%
$34.08
+32.6%
-29.6%$3.76B$3.84B30.6120,800
TXG
10x Genomics
4.3995 of 5 stars
$9.45
-0.8%
$15.81
+67.3%
-53.9%$1.16B$624.66M-6.221,240High Trading Volume
TRNS
Transcat
2.402 of 5 stars
$85.44
-2.2%
$114.00
+33.4%
-39.3%$796.13M$278.42M46.18920Analyst Revision
ALNT
Allient
3.4509 of 5 stars
$30.34
-0.2%
$31.00
+2.2%
+28.3%$513.63M$516.06M34.481,950Positive News

Related Companies and Tools


This page (NASDAQ:CAMT) was last updated on 6/10/2025 by MarketBeat.com Staff
From Our Partners